Explaining the high rate of progression from prediabetes to type 2 diabetes in China - Authors' reply.
Gespeichert in:
| Titel: | Explaining the high rate of progression from prediabetes to type 2 diabetes in China - Authors' reply. |
|---|---|
| Autoren: | Zhang L; The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China., Gong Q; Department of Endocrinology, Fuwai Hospital and Chinese Academy of Medical Sciences, Beijing 100037, China., Sun N; Department of Hypertension, Peking University People's Hospital, Beijing, China., Ji L; Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China., Li G; Department of Endocrinology, Fuwai Hospital and Chinese Academy of Medical Sciences, Beijing 100037, China. Electronic address: guangwei_li45@126.com. |
| Quelle: | The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2023 Nov; Vol. 11 (11), pp. 794-795. |
| Publikationsart: | Letter; Comment |
| Sprache: | English |
| Info zur Zeitschrift: | Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: London : The Lancet, Diabetes & Endocrinology, [2013]- |
| MeSH-Schlagworte: | Prediabetic State*/epidemiology , Diabetes Mellitus, Type 2*/epidemiology, Humans ; Risk Factors ; Blood Glucose ; China/epidemiology |
| Abstract: | Competing Interests: LZ, QG, NS, and GL received research support from the Chinese Association of Geriatric Research. LJ served as a consultant and spoke at scientific meetings for Merck Serono China. |
| Kommentare: | Comment on: Lancet Diabetes Endocrinol. 2023 Aug;11(8):567-577. doi: 10.1016/S2213-8587(23)00132-8. (PMID: 37414069) Comment on: Lancet Diabetes Endocrinol. 2023 Nov;11(11):794. doi: 10.1016/S2213-8587(23)00282-6. (PMID: 37884324) |
| Substance Nomenclature: | 0 (Blood Glucose) |
| Entry Date(s): | Date Created: 20231026 Date Completed: 20231030 Latest Revision: 20231031 |
| Update Code: | 20250114 |
| DOI: | 10.1016/S2213-8587(23)00283-8 |
| PMID: | 37884323 |
| Datenbank: | MEDLINE |
Nájsť tento článok vo Web of Science | Abstract: | Competing Interests: LZ, QG, NS, and GL received research support from the Chinese Association of Geriatric Research. LJ served as a consultant and spoke at scientific meetings for Merck Serono China. |
|---|---|
| ISSN: | 2213-8595 |
| DOI: | 10.1016/S2213-8587(23)00283-8 |